SAN DIEGO--(BUSINESS WIRE)--Imagenetix, Inc. (OTCBB: IAGX) today announced that its
proprietary anti-inflammatory compound, 1-tetradecanol complex (1-TDC),
intended for use in the...
SAN DIEGO--(BUSINESS WIRE)--Imagenetix, Inc. (OTCBB:IAGX) today announced that, for the
second fiscal quarter ended September 30, 2006, it reported revenue of
$1,333,016, compared to...
SAN DIEGO--(BUSINESS WIRE)--Imagenetix, Inc. (OTCBB: IAGX) today announced that, effectively
immediately, it will market its branded joint health formula to
professional sports teams...
SAN DIEGO--(BUSINESS WIRE)--Aug. 21, 2006--Imagenetix, Inc. (OTCBB: IAGX) today announced a comprehensive nationwide retail branding program for its proprietary products. The first products to be...
SAN DIEGO--(BUSINESS WIRE)--Aug. 14, 2006--Imagenetix, Inc. (OTCBB:IAGX) today announced that, for the first fiscal quarter ended June 30, 2006, it reported revenue of $931,569, compared to revenue...
SAN DIEGO--(BUSINESS WIRE)--June 29, 2006--Imagenetix, Inc. (OTCBB:IAGX) today announced that, for the fiscal year ended March 31, 2006, it reported revenue of $7,649,941, a 1 percent increase on...
SAN DIEGO--(BUSINESS WIRE)--June 26, 2006--Imagenetix, Inc. (OTCBB:IAGX) today announced it has engaged the services of Michael Hamrell, Ph.D., president of MORIAH Consultants, a regulatory affairs...
SAN DIEGO--(BUSINESS WIRE)--Nov. 30, 2005--Imagenetix, Inc. (OTCBB:IAGX), a company focused on inflammation and inflammation-related markets, today said its Celadrin(R) supplement for joint health...
SAN DIEGO--(BUSINESS WIRE)--Nov. 16, 2005--Imagenetix, Inc. (OTCBB:IAGX), an innovator of scientifically tested, natural-based, proprietary bioceutical products that enhance human health, today...
SAN DIEGO--(BUSINESS WIRE)--Sept. 27, 2005--Imagenetix, Inc. (OTCBB:IAGX), www.imagenetix.net a company focused on inflammation and inflammation related markets, today announced the appointment of...
SAN DIEGO--(BUSINESS WIRE)--Sept. 26, 2005--Imagenetix, Inc. (OTCBB:IAGX), www.imagenetix.net, a company focused on inflammation and inflammation-related markets, today announced Bob Burg has...
#7: IAGX News Imagenetix Reports Record Quarter; Sales Hit All Time High -- Up 142%; Before-Tax Income Soars 174%; Company Reports Ten Consecutive Quarters of Operating Profits
SAN DIEGO--(BUSINESS WIRE)--Aug. 16, 2005--Imagenetix, Inc. (OTCBB:IAGX), www.imagenetix.net, a company focused on inflammation and inflammation-related markets, announces the results for the first...
SAN DIEGO--(BUSINESS WIRE)--July 20, 2005--Imagenetix, Inc. (OTCBB:IAGX), www.imagenetix.net, a company focused on inflammation and inflammation related markets announces the results for the fourth...
Jason Theodosakis and Lorna Vanderhaeghe Join Imagenetix's Scientific and Medical Advisory Board
SAN DIEGO
Imagenetix, Inc.
Patrick Millsap, 858-674-8455
Imagenetix, Inc. (OTCBB: IAGX),...
Joining the Imagenetix Scientific and Medical Advisory Board are Robert B. Zurier, M.D. and William J. Kraemer, Ph.D.
SAN DIEGO
Imagenetix, Inc.
Patrick Millsap, 858-674-8455
Imagenetix,...